Our Relationships

Innovative companies, successful investors

We partner with many of the most innovative, public and private biopharma companies in the industry, at the most formative stages of their life cycles – from discovery, development and into commercialization and throughout all stages of capitalization. 

Our clients are supported by some of the most sophisticated investors the space, who believe in leaders who can advance paradigm-changing science and develop life-saving therapeutics for patients. 

 Biopharma


  • Aerium Therapeutics
  • Agios
  • Alkeus Pharmaceuticals
  • ALX Oncology
  • AvroBio
  • Blueprint Medicines
  • C4 Therapeutics
  • Carisma
  • Chinook
  • Cidara Therapeutics
  • Codiak BioSciences
  • CRISPR Therapeutics
  • DVB Technologies
  • editas Medicine
  • enGene
  • Frequenct Theraputics
  • Halozyme
  • Hillstar Bio
  • HotSpot Therapeutics
  • Hyku Biosciences
  • Judo Bio
  • Korro Bio
  • KSQ
  • KYMERA
  • MarcoGenics
  • Merus
  • Mirati
  • Monte Rosa
  • Nested Therapeutics
  • Nuvation Bio
  • Optinose
  • Parabilis Medicines
  • Prelude
  • Provention Bio
  • Rectify Pharma
  • Remix Therapeutics
  • Ribon Therapeutics
  • Rhythm
  • ROME Therapeutics
  • Santa Ana Bio
  • Sarepta Therapeutics
  • Seagen
  • Second Genome
  • Solid Biosciences
  • Spero
  • Stoke Therapeutics
  • Tallac
  • Tenaya Therapeutics
  • TScan Therapeutics
  • Whitehawk Therapeutics
  • Xilio Therapeutics

 Investors


  • ALEXANDRIA
  • Arch
  • Blackstone
  • Casdin
  • Column Group
  • forbion
  • Foresite Capital
  • F Prime
  • Frazier
  • GV
  • Khosla ventures
  • Lightstone
  • Longitude Capital
  • Lundbeckfond
  • mpm
  • NEA
  • NVF
  • novo holdings
  • omega Funds
  • OrbiMed
  • Perspective Advisors
  • Pfizer
  • Polaris
  • ra capital
  • section 32
  • SOFINNOVA
  • SR ONE
  • SV HEALTH INVESTORS
  • THIRD ROCK
  • TPG
  • VEN BIO
  • VENROCK
  • VERSANT
  • VIDA

Follow us on LinkedIn and X to stay updated on announcements, news, and opportunities.